Abiraterone for Prostate Cancer Not Previously Treated with Hormone TherapyNicholas D. James, Matthew R. Sydes, Noel W. Clarke et al.|New England Journal of Medicine|2017Cited by 1.8k
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.Nicholas D. James, Laura Murphy, Noel W. Clarke et al.|BORIS (University Library Bern)|2022Cited by 311